These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32022594)

  • 1. A Prospective Longitudinal Investigation of Cortical Thickness and Gyrification in Schizophrenia.
    Nelson EA; Kraguljac NV; White DM; Jindal RD; Shin AL; Lahti AC
    Can J Psychiatry; 2020 Jun; 65(6):381-391. PubMed ID: 32022594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early alterations of cortical thickness and gyrification in migraine without aura: a retrospective MRI study in pediatric patients.
    Guarnera A; Bottino F; Napolitano A; Sforza G; Cappa M; Chioma L; Pasquini L; Rossi-Espagnet MC; Lucignani G; Figà-Talamanca L; Carducci C; Ruscitto C; Valeriani M; Longo D; Papetti L
    J Headache Pain; 2021 Jul; 22(1):79. PubMed ID: 34294048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical morphological changes in multiple sclerosis patients: a study of cortical thickness, sulcal depth, and local gyrification index.
    Genç B; Aslan K; Şen S; İncesu L
    Neuroradiology; 2023 Sep; 65(9):1405-1413. PubMed ID: 37344675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral cortical thickness and gyrification changes in first-episode psychoses and multi-episode schizophrenia.
    Del Casale A; Rossi-Espagnet MC; Napolitano A; Lucignani M; Bonanni L; Kotzalidis GD; Buscajoni A; Manelfi L; Perrone V; Gualtieri I; Brugnoli R; De Pisa E; Girardi P; Romano A; Ferracuti S; Bozzao A; Pompili M
    Arch Ital Biol; 2021 Mar; 159(1):3-20. PubMed ID: 34159573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gyrification Connectomes in Unmedicated Patients With Schizophrenia and Following a Short Course of Antipsychotic Drug Treatment.
    Nelson EA; White DM; Kraguljac NV; Lahti AC
    Front Psychiatry; 2018; 9():699. PubMed ID: 30618873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
    Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
    J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
    Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
    PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced cortical thickness and increased gyrification in generalized anxiety disorder: a 3 T MRI study.
    Molent C; Maggioni E; Cecchetto F; Garzitto M; Piccin S; Bonivento C; Maieron M; D'Agostini S; Balestrieri M; Perna G; Altamura AC; Brambilla P
    Psychol Med; 2018 Sep; 48(12):2001-2010. PubMed ID: 29239286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.
    Lesh TA; Tanase C; Geib BR; Niendam TA; Yoon JH; Minzenberg MJ; Ragland JD; Solomon M; Carter CS
    JAMA Psychiatry; 2015 Mar; 72(3):226-34. PubMed ID: 25588194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study.
    Kraguljac NV; White DM; Hadley N; Hadley JA; Ver Hoef L; Davis E; Lahti AC
    Schizophr Bull; 2016 Jul; 42(4):1046-55. PubMed ID: 26873890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics Effects on Network-Level Reconfiguration of Cortical Morphometry in First-Episode Schizophrenia.
    Jiang Y; Wang Y; Huang H; He H; Tang Y; Su W; Xu L; Wei Y; Zhang T; Hu H; Wang J; Yao D; Wang J; Luo C
    Schizophr Bull; 2022 Jan; 48(1):231-240. PubMed ID: 34313782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right superior frontal gyrus: A potential neuroimaging biomarker for predicting short-term efficacy in schizophrenia.
    Yang Y; Jin X; Xue Y; Li X; Chen Y; Kang N; Yan W; Li P; Guo X; Luo B; Zhang Y; Liu Q; Shi H; Zhang L; Su X; Liu B; Lu L; Lv L; Li W
    Neuroimage Clin; 2024; 42():103603. PubMed ID: 38588618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered brain gyrification in deficit and non-deficit schizophrenia.
    Takayanagi Y; Sasabayashi D; Takahashi T; Komori Y; Furuichi A; Kido M; Nishikawa Y; Nakamura M; Noguchi K; Suzuki M
    Psychol Med; 2019 Mar; 49(4):573-580. PubMed ID: 29739476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cortical hypogyrification pattern in antipsychotic-naive first-episode schizophrenia.
    Gao X; Yao L; Li F; Yang C; Zhu F; Gong Q; Lui S
    Cereb Cortex; 2023 Jun; 33(12):7619-7626. PubMed ID: 36916957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical features of distinct developmental trajectories in patients with delusional infestation.
    Hirjak D; Huber M; Kirchler E; Kubera KM; Karner M; Sambataro F; Freudenmann RW; Wolf RC
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():72-79. PubMed ID: 28257853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insular changes induced by electroconvulsive therapy response to symptom improvements in schizophrenia.
    Jiang Y; Xia M; Li X; Tang Y; Li C; Huang H; Dong D; Jiang S; Wang J; Xu J; Luo C; Yao D
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():254-262. PubMed ID: 30248379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State-independent and -dependent structural alterations in limbic-cortical regions in patients with current and remitted depression.
    Xiong G; Dong D; Cheng C; Jiang Y; Sun X; He J; Li C; Gao Y; Zhong X; Zhao H; Wang X; Yao S
    J Affect Disord; 2019 Nov; 258():1-10. PubMed ID: 31382099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses.
    Ajnakina O; Das T; Lally J; Di Forti M; Pariante CM; Marques TR; Mondelli V; David AS; Murray RM; Palaniyappan L; Dazzan P
    Schizophr Bull; 2021 Oct; 47(6):1729-1739. PubMed ID: 33851203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrification.
    Rosa PGP; Zugman A; Cerqueira CT; Serpa MH; de Souza Duran FL; Zanetti MV; Bassitt DP; Elkis H; Crippa JAS; Sallet PC; Gattaz WF; Hallak JEC; Louzã MR; Gadelha A; Jackowski AP; Bressan RA; Filho GB
    Schizophr Res; 2021 Oct; 236():104-114. PubMed ID: 34481405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.
    Goghari VM; Smith GN; Honer WG; Kopala LC; Thornton AE; Su W; Macewan GW; Lang DJ
    Schizophr Res; 2013 Sep; 149(1-3):149-55. PubMed ID: 23830856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.